Biolitec AG  

(Public, ETR:BIB)   Watch this stock  
Find more results for BIB
0.0000
Delayed:  
ETR data delayed by 15 mins - Disclaimer
Currency in
Range     -
52 week 1.80 - 2.50
Open     -
Vol / Avg. 0.00/382.00
Mkt cap     -
P/E     -
Div/yield     -
EPS -0.68
Shares 10.52M
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 14.48% -22.66%
Operating margin 1.58% -14.67%
EBITD margin - -4.66%
Return on average assets 10.67% -14.14%
Return on average equity 12.61% -17.20%
Employees 241 -
Carbon Disclosure Rating - -

Address

Otto-Schott-Str. 15
JENA, 07745
Germany
+49-3641-508550 (Phone)
+49-3641-508599 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

Biolitec AG is a Germany-based holding company primarily active in the pharmaceutical sector. It specializes in the manufacture, development and sale of laser diodes, fiber optic-based materials and photodynamic agents. The Company operates two segments: Meditec and Pharma. The Meditec segment encompasses the production of laser probes and light transmitters for medical purposes. Those products are manufactured in Bonn, Germany, as well as in the United States and Latvia. The Company's lasers are additionally produces also in Malaysia. The Pharma segment comprises the manufacturing, development and sale of pharmaceutical substances. The Company is majority owned by Biomed Technology Holding and operates subsidiaries located in Malaysia, the United States, Italy, and Russia, among others.